Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-06-30
2000-06-20
Venkat, Jyothsna
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514887, A61K 3578
Patent
active
060775122
ABSTRACT:
An externally-applied medicine for curing black foot disease comprising a basis part consisting of equal amount of ground, powdered, and mixed clove, frankincense, myrrha, rhizama arisaematis, pinellia, monkshood (root) or kusnezoff monkshood (root), and tuber of bamboo-leaved orchid, and an adjuvant part consisting of equal amount of round, powdered, and mixed borneol, powdered soy bean, borax, coptis root and/or phellodendron amureuse, and sepia aculeata. The medicine is used in such a manner that the powdered basis part is mixed and stirred with tea water until it becomes plaster-like, and the adjuvant part is scattered in dry form onto the wound or swollen area caused by the black foot disease before the plaster-like basis part is applied to the wound or swollen area about 0.5 cm in thickness. The wound is then bandaged and the medicine is renewed once to twice a day until fresh flesh appears in the wound. Thereafter, the medicine is continuously applied but in a dry form until the wound is completely healed.
REFERENCES:
patent: 5595743 (1997-01-01), Wu
LandOfFree
Externally-applied medicine for curing black foot disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Externally-applied medicine for curing black foot disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Externally-applied medicine for curing black foot disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849830